Fig. 3

EVP contribution to arterial and venous beds. Representative micrographs of tumor sections taken from Cdh5-CreER RosaYFP and Sox18-CreER RosaYFP lineage tracing models. At day 5 YFP+ cells did not display any arterial or venous markers. By day 10 and 15 YFP+ cells could be co-localized with arterial marker DLL4 and venous marker endomucin (n = 5). Results presented as mean ± SEM. Scale bar represents 150 μm